{"slug":"mesothelioma","tag":"mesothelioma","variants":["mesothelioma"],"description":"No description yet","count":5,"kinds":{"person":5},"related":[{"slug":"immunotherapy","tag":"immunotherapy","shared":4},{"slug":"australia","tag":"australia","shared":1},{"slug":"guidelines","tag":"guidelines","shared":1},{"slug":"pancreatic","tag":"pancreatic","shared":1},{"slug":"surgery","tag":"surgery","shared":1},{"slug":"trialist","tag":"trialist","shared":1},{"slug":"uk","tag":"uk","shared":1}],"records":[{"id":"hedy-kindler","kind":"person","name":"Hedy L. Kindler","route":"/people/hedy-kindler/","tldr":"Senior investigator of POLO and a leader in mesothelioma trials, including the ASCO guidelines for the disease."},{"id":"paul-baas","kind":"person","name":"Paul Baas","route":"/people/paul-baas/","tldr":"Led CheckMate 743, the trial that gave mesothelioma its first new first-line therapy in 16 years."},{"id":"dean-fennell","kind":"person","name":"Dean A. Fennell","route":"/people/dean-fennell/","tldr":"Led CONFIRM and MARS 2, which showed nivolumab helps relapsed mesothelioma and that radical surgery does not."},{"id":"anna-nowak","kind":"person","name":"Anna K. Nowak","route":"/people/anna-nowak/","tldr":"Australian oncologist who led DREAM and DREAM3R, testing durvalumab with chemotherapy in mesothelioma."},{"id":"quincy-chu","kind":"person","name":"Quincy Chu","route":"/people/quincy-chu/","tldr":"Edmonton oncologist who was lead author of KEYNOTE-483 (CCTG IND.227), the trial that showed adding pembrolizumab to chemotherapy lengthens survival in pleural mesothelioma."}]}